BioCentury
ARTICLE | Company News

Seaside Therapeutics, Roche deal

June 25, 2012 7:00 AM UTC

Roche and Seaside partnered to develop disease modifying treatments for fragile X syndrome and autism spectrum disorders. Seaside will grant Roche an exclusive license to IP covering metabotropic glu...